Skip to Content
Full Title TED-C14-006/ 2-dose Teduglutide
Protocol Number
Principal Investigator(s) Peter F Nichol, MD, PhD
Division General Surgery
Status New

The objective of this clinical study is to evaluate the safety, tolerability, efficacy, and pharmacodynamic effects of teduglutide in pediatric subjects (aged 1 year through 17 years) with short bowel syndrome (SBS) who are dependent on parenteral support.

Other Clinical Trials in the Department of Surgery Copyright © 2016 The Board of Regents of the University of Wisconsin System